Roman Skoracki was named medical director of the Stefanie Spielman Comprehensive Breast Center (SSCBC) at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has announced three senior leadership appointments.
Virginia Commonwealth University Health System opened the Adult Outpatient Pavilion, which is now the system’s largest outpatient facility.
The National Comprehensive Cancer Network has concluded its 2021 Patient Advocacy Summit, which focused on expanding precision medicine in order to improve cancer outcomes, featuring discussions on federal and local policies to broaden genetic/genomic testing access.
Experts will convene at the third Miami Cancer Institute Summit of Americas on Immunotherapies for Hematologic Malignancies in January 2022 to discuss advances in immunologically and molecular based system therapies, new-targeted diagnostic and therapeutic strategies for lymphoma, myeloma, and leukemia, the role and timing of hematopoietic cell transplantation, and the latest on CAR T-cell therapies.
The American Society for Radiation Oncology issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson in response to the introduction of the Supporting Health Care Providers During the COVID-19 Pandemic Act in the U.S. House of Representatives.
Sharon Wilks joined NEXT Oncology’s phase I clinical investigation team, bringing more than 30 years of research and clinical experience to the practice.
The FDA Oncology Center of Excellence is accepting applied research proposals for five-year research contracts.
Researchers at Penn Medicine have illuminated key molecular details of the T-cell exhaustion process, identifying a specific strategy for making chimeric antigen receptor (CAR) T cell-therapy more effective against solid tumors.
A study led by Susan G. Komen Brinker Award winner Carlos Caldas found that there may be a way to predict treatment response in breast cancer patients even before treatment begins. Results will be presented at the 2021 San Antonio Breast Cancer Symposium Dec. 7-10.
